Table 1 Case Characteristics
Clinical information | Genomic information | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Sample number | Age (years) | Sex | Tumor site | Clinical notes/follow-up | Total calls | % Genome altered | Tumor content (%) | Clonal burden (%) | Clonal diversity? | Griffin et al case # | % Concordance (# calls) for copy-number alterations |
1 | 39 | Male | Peri-duodenum, metastasis to bile duct | SR then XRT at time of primary diagnosis; CT for multiple LR and M beginning at 11 months; DFD at 37 months after first diagnosis | 69 | 62 | 75 | ND | ND | 4 | 100% (4) |
2 | 19 | Female | Neck (nodal) | 7.5 year history of mass; no follow-up available | 38 | 54 | 65 | 70 | Yes | — | — |
3 | 61 | Male | Retroperitoneal, colon | DFD at 15 months after diagnosis | 33 | 27 | 70 | 30 | No | — | — |
4 | 56 | Male | Liver | CT at time of primary diagnosis; SR at 9 months; CT for LR and M beginning at 21 months; AWD at 56 months after first diagnosis | 31 | 42 | 90 | 55 | Yes | 5 | 75% (4) |
5 | 60 | Female | Porta hepatis, metastasis to omentum | CT at time of primary diagnosis; SDB for RPD and M at 17 months; no clinical follow-up available after SDB | 31 | 27 | 40 | 55 | No | 2 | 100% (4) |
6 | 60 | Male | Chest wall | SR at time of primary diagnosis; SR and XRT for LR at 32 months; ANED at 61 months after first diagnosis | 28 | 62 | 90 | 80 | Yes | 1 | 100% (4)a |
7 | 22 | Male | Neck (nodal) | No follow-up available | 21 | 24 | 90 | 50 | ND | — | — |
8 | 40 | Male | GI Mass, Duodenum | DFD at 29 months after diagnosis | 20 | 38 | 70 | 35 | ND | — | — |
9 | 48 | Male | Supraclavicular fossa | SR then XRT at time of primary diagnosis; CT for multiple LR and M beginning at 11 months; DFD at 37 months after first diagnosis | 10 | 14 | 70 | 40 | ND | 3 | 100% (1)a |
10 | 40 | Female | Peritoneal | DFD at 32 months after diagnosis | 5 | 18 | 70 | 20 | No | — | — |
11 | 26 | Male | Tonsil/neck mass (nodal) | No follow-up available | 4 | 14 | 60 | 20 | ND | 6b | — |
12 | 77 | Female | Ovary | No follow-up available | 0 | 0 | 80 | — | — | — | — |
13 | 40 | Female | Lymph node, Retroperitoneal | No follow-up available | 0 | 0 | 60 | — | — | — | — |
14 | 66 | Female | Lymph node, Periadnexal mass | Abdominal pain, no follow-up available | 0 | 0 | 70 | — | — | — | — |